ZEB1 and melanoma: Melanoma samples carrying BRAF or RAS mutations presented significantly higher expression levels of ZEB1-AS1 (P-value < 0.001 and P-value < 0.05, respectively) when compared to the Triple Wild-Type group (Fig. 3d).